Activation of blood coagulation in patients with major depressive disorder during euglycemic hyperinsulinemia.
Horne
McDonald K
MK
Hematology Service, Department of Laboratory Medicine, W. G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20895, United States. mhorne@mail.cc.nih.gov
Merryman
Paula K
PK
Cullinane
Ann M
AM
Cai
June
J
Martinez
Pedro E
PE
Kling
Mitchel A
MA
Gold
Philip W
PW
D000328:Adult; D000990:Antithrombin III; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation; D016022:Case-Control Studies; D003865:Major Depressive Disorder / Q000097:blood*; D005169:Factor VIII / Q000032:analysis; D005260:Female; D015309:Glucose Clamp Technique / Q000009:adverse effects*; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000097:blood; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D010959:Tissue Plasminogen Activator / Q000097:blood
D015415:Biomarkers; D017395:Plasminogen Activator Inhibitor 1; C046193:antithrombin III-protease complex; D000990:Antithrombin III; D005169:Factor VIII; D010447:Peptide Hydrolases; D010959:Tissue Plasminogen Activator